[Federal Register Volume 71, Number 160 (Friday, August 18, 2006)]
[Notices]
[Pages 47782-47783]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-7007]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License of a U.S. Government-Owned 
Patent

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(I)(i), 
announcement is made of the intent to grant an exclusive, royalty-
bearing, revocable license to U.S. patent number 6,399,332 issued June 
4, 2002 entitled ``Bacterial Superantigen Vaccines,'' and U.S. patent 
number 6,713,284 issued March 30, 2004 entitled ``Bacterial 
Superantigen Vaccines,'' and all pending foreign patents to Integrated 
Biotherapeutics, Inc. with its principal place of business at Frederick 
Innovative Technology Center, Rosenstock Hall, Frederick, MD 21702.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to the grant of 
this license can file written objections along

[[Page 47783]]

with supporting evidence, if any, 15 days from the date of this 
publication. Written objections are to be filed with the Command Judge 
Advocate (see ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 06-7007 Filed 8-17-06; 8:45am]
BILLING CODE 3710-08-M